Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
CC transcript
ALNYLAM PHARMACEUTICALS, INC. (ALNY) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2023 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 3.3% stake in ALNYLAM PHARMACEUTICALS INC
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 9.4% stake in Alnylam Pharmaceuticals Inc.
02/09/2023 SC 13G/A FMR LLC reports a 11% stake in ALNYLAM PHARMACEUTICALS INC
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/31/2023 SC 13G/A BlackRock Inc. reports a 7% stake in ALNYLAM PHARMACEUTICALS INC
01/19/2023 SC 13G/A BAILLIE GIFFORD & CO reports a 7.6% stake in ALNYLAM PHARMACEUTICALS
02/09/2022 SC 13G/A VANGUARD GROUP INC reports a 9% stake in Alnylam Pharmaceuticals Inc.
02/09/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/04/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/02/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/18/2022 SC 13G/A BAILLIE GIFFORD & CO reports a 8.9% stake in ALNYLAM PHARMACEUTICALS
02/10/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/08/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/03/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/01/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/14/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2020 SC 13G/A VANGUARD SPECIALIZED FUNDS reports a 0% stake in Alnylam Pharmaceuticals Inc
02/07/2020 SC 13G/A FMR LLC reports a 15% stake in ALNYLAM PHARMACEUTICALS INC
02/05/2020 SC 13G/A BlackRock Inc. reports a 7.2% stake in ALNYLAM PHARMACEUTICALS INC
01/28/2020 SC 13G/A WELLINGTON MANAGEMENT GROUP LLP reports a 12.8% stake in Alnylam Pharmaceuticals, Inc.
05/03/2019 SC 13G/A Sanofi reports a 0% stake in Alnylam Pharmaceuticals, Inc.
02/14/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/11/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/04/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/31/2019 SC 13G/A VANGUARD SPECIALIZED FUNDS reports a 9% stake in Alnylam Pharmaceuticals Inc
06/11/2018 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 7.1% stake in ALNYLAM PHARMACEUTICALS, INC.
05/10/2018 SC 13G/A WELLINGTON MANAGEMENT GROUP LLP reports a 10.7% stake in Alnylam Pharmaceuticals, Inc.
02/14/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2018 SC 13G/A Sanofi reports a 11.4% stake in Alnylam Pharmaceuticals, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy